ISG15 in antiviral immunity and beyond (original) (raw)

• Schneider, W. M., Chevillotte, M. D. & Rice, C. M. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513–545 (2014).
  CAS PubMed PubMed Central Google Scholar
• Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623–15628 (1998).
  CAS PubMed Google Scholar
• Loeb, K. R. & Haas, A. L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267, 7806–7813 (1992).
  CAS PubMed Google Scholar
• Zhang, X. et al. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature 517, 89–93 (2015). This study identifies a second cohort of individuals lacking ISG15 who presented with evidence of interferon hypersensitivity. They demonstrated that human ISG15 non-covalently binds to USP18, preventing its ubiquitylation and subsequent degradation, and therefore functions as a key negative regulator of type I interferon signalling.
  CAS PubMed Google Scholar
• Bogunovic, D. et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337, 1684–1688 (2012). This groundbreaking study reports the first ISG15-deficient individuals. The findings indicate that these patients developed disseminated mycobacterial disease after bacillus Calmette–Guérin (BCG) vaccination and reveal that cells derived from these patients produced reduced levels of IFNγ after stimulation with Mycobacterium owing to the loss of extracellular ISG15 and its ability to function as a cytokine to stimulate IFNγ production.
  CAS PubMed PubMed Central Google Scholar
• Korant, B. D., Blomstrom, D. C., Jonak, G. J. & Knight, E. Jr. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J. Biol. Chem. 259, 14835–14839 (1984).
  CAS PubMed Google Scholar
• Haas, A. L., Ahrens, P., Bright, P. M. & Ankel, H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262, 11315–11323 (1987).
  CAS PubMed Google Scholar
• Blomstrom, D. C., Fahey, D., Kutny, R., Korant, B. D. & Knight, E. Jr. Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J. Biol. Chem. 261, 8811–8816 (1986).
  CAS PubMed Google Scholar
• Dao, C. T. & Zhang, D. E. ISG15: a ubiquitin-like enigma. Front. Biosci. 10, 2701–2722 (2005).
  CAS PubMed Google Scholar
• Narasimhan, J. et al. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J. Biol. Chem. 280, 27356–27365 (2005).
  CAS PubMed Google Scholar
• Yuan, W. & Krug, R. M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20, 362–371 (2001).
  CAS PubMed PubMed Central Google Scholar
• Radoshevich, L. et al. ISG15 counteracts Listeria monocytogenes infection. eLife 4, e06848 (2015).
  PubMed Central Google Scholar
• Malakhova, O., Malakhov, M., Hetherington, C. & Zhang, D. E. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277, 14703–14711 (2002).
  CAS PubMed Google Scholar
• Pitha-Rowe, I., Hassel, B. A. & Dmitrovsky, E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J. Biol. Chem. 279, 18178–18187 (2004).
  CAS PubMed Google Scholar
• Liu, M., Hummer, B. T., Li, X. & Hassel, B. A. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J. Interferon Cytokine Res. 24, 647–654 (2004).
  CAS PubMed Google Scholar
• Potter, J. L., Narasimhan, J., Mende-Mueller, L. & Haas, A. L. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein. J. Biol. Chem. 274, 25061–25068 (1999).
  CAS PubMed Google Scholar
• Zhang, D. & Zhang, D. E. Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 31, 119–130 (2011).
  CAS PubMed PubMed Central Google Scholar
• Giannakopoulos, N. V. et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 336, 496–506 (2005).
  CAS PubMed Google Scholar
• Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S. & Krug, R. M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl Acad. Sci. USA 102, 10200–10205 (2005).
  CAS PubMed Google Scholar
• Liu, M., Li, X. L. & Hassel, B. A. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J. Biol. Chem. 278, 1594–1602 (2003).
  CAS PubMed Google Scholar
• Desai, S. D. et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 66, 921–928 (2006).
  CAS PubMed Google Scholar
• Fan, J. B. et al. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis. Sci. Rep. 5, 12704 (2015).
  CAS PubMed PubMed Central Google Scholar
• Jeon, Y. J. et al. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep. 10, 374–380 (2009).
  CAS PubMed PubMed Central Google Scholar
• Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J. & Zhang, D. E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976–9981 (2002).
  CAS PubMed Google Scholar
• Basters, A. et al. Structural basis of the specificity of USP18 toward ISG15. Nat. Struct. Mol. Biol. 24, 270–278 (2017). This structural-based study characterizes how USP18 specifically recognizes and deconjugates ISG15-conjugated proteins.
  CAS PubMed PubMed Central Google Scholar
• Malakhova, O. A. et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358–2367 (2006). This was the first paper to demonstrate that, in addition to functioning as a deISGylase, USP18 also binds to the type I interferon receptor and functions as a critical negative regulator of interferon signalling.
  CAS PubMed PubMed Central Google Scholar
• Knobeloch, K. P., Utermohlen, O., Kisser, A., Prinz, M. & Horak, I. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25, 11030–11034 (2005).
  CAS PubMed PubMed Central Google Scholar
• Knight, E. Jr & Cordova, B. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146, 2280–2284 (1991).
  CAS PubMed Google Scholar
• D’Cunha, J. et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157, 4100–4108 (1996).
  PubMed Google Scholar
• Lai, C. et al. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J. Virol. 83, 1147–1151 (2009).
  CAS PubMed Google Scholar
• Werneke, S. W. et al. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 7, e1002322 (2011). This is the first in vivo study to indicate that unconjugated ISG15 can protect the host from viral infection by functioning as a critical immunomodulatory molecule.
  CAS PubMed PubMed Central Google Scholar
• D’Cunha, J. et al. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl Acad. Sci. USA 93, 211–215 (1996).
  PubMed Google Scholar
• Padovan, E. et al. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res. 62, 3453–3458 (2002).
  CAS PubMed Google Scholar
• Owhashi, M. et al. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem. Biophys. Res. Commun. 309, 533–539 (2003).
  CAS PubMed Google Scholar
• Sun, L. et al. Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages. Antiviral Res. 134, 167–171 (2016).
  CAS PubMed PubMed Central Google Scholar
• Dos Santos, P. F. & Mansur, D. S. Beyond ISGlylation: functions of free intracellular and extracellular ISG15. J. Interferon Cytokine Res. 37, 246–253 (2017).
  PubMed Google Scholar
• Swaim, C. D., Scott, A. F., Canadeo, L. A. & Huibregtse, J. M. Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor. Mol. Cell 68, 581–590.e5 (2017). This paper identifies the first cell surface receptor for ISG15 and demonstrates its ability to augment IFNγ secretion from cells that were primed with IL-12.
  CAS PubMed PubMed Central Google Scholar
• Narasimhan, J., Potter, J. L. & Haas, A. L. Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J. Biol. Chem. 271, 324–330 (1996).
  CAS PubMed Google Scholar
• Okumura, A., Pitha, P. M. & Harty, R. N. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl Acad. Sci. USA 105, 3974–3979 (2008). This mechanistic study shows that ISG15 inhibits viral budding by targeting the E3 ligase activity of NEDD4.
  CAS PubMed Google Scholar
• Nakashima, H., Nguyen, T., Goins, W. F. & Chiocca, E. A. Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62. J. Biol. Chem. 290, 1485–1495 (2015).
  PubMed Google Scholar
• Du, Y. et al. LRRC25 inhibits type I IFN signaling by targeting ISG15-associated RIG-I for autophagic degradation. EMBO J. 37, 351–366 (2018).
  CAS PubMed Google Scholar
• Lenschow, D. J. et al. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79, 13974–13983 (2005).
  CAS PubMed PubMed Central Google Scholar
• Sampson, D. L. et al. A four-biomarker blood signature discriminates systemic inflammation due to viral infection versus other etiologies. Sci. Rep. 7, 2914 (2017).
  CAS PubMed PubMed Central Google Scholar
• Morales, D. J. & Lenschow, D. J. The antiviral activities of ISG15. J. Mol. Biol. 425, 4995–5008 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hermann, M. & Bogunovic, D. ISG15: in sickness and in health. Trends Immunol. 38, 79–93 (2017).
  CAS PubMed Google Scholar
• Giannakopoulos, N. V. et al. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J. Virol. 83, 1602–1610 (2009).
  CAS PubMed Google Scholar
• Lenschow, D. J. et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl Acad. Sci. USA 104, 1371–1376 (2007). This is the first in vivo study of ISG15-deficient mice, which demonstrates that ISG15 protected mice from viral-induced lethality and that it is critical in the host response to viral infection.
  CAS PubMed Google Scholar
• Rahnefeld, A. et al. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation 130, 1589–1600 (2014). This paper indicates that ISG15 conjugation has a critical role in controlling CVB3 viral replication and viral-induced cardiomyopathy.
  CAS PubMed Google Scholar
• Ketscher, L. et al. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc. Natl Acad. Sci. USA 112, 1577–1582 (2015). The authors generate Usp18 -knock-in mice in which USP18 is mutated so it cannot function as a deISGylase but still maintains its ability to negatively regulate interferon signalling. Analysis of these mice reveals that an increase in ISGylation could mediate viral resistance.
  CAS PubMed Google Scholar
• Morales, D. J. et al. Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice. J. Virol. 89, 337–349 (2015). This paper describes the ability of ISG15 to protect the host from viral-induced lethality, independent of its effects on viral replication (a process defined as disease tolerance).
  PubMed Google Scholar
• Xu, D. et al. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon. Autophagy 11, 617–628 (2015).
  CAS PubMed PubMed Central Google Scholar
• Baldanta, S. et al. ISG15 governs mitochondrial function in macrophages following vaccinia virus infection. PLoS Pathog. 13, e1006651 (2017).
  PubMed PubMed Central Google Scholar
• Speer, S. D. et al. ISG15 deficiency and increased viral resistance in humans but not mice. Nat. Commun. 7, 11496 (2016). This paper describes differences in viral resistance between human and mouse cells lacking ISG15 and demonstrates that this is due to the differential ability of human and mouse ISG15 to negatively regulate IFNα and IFNβ signalling.
  CAS PubMed PubMed Central Google Scholar
• Durfee, L. A., Lyon, N., Seo, K. & Huibregtse, J. M. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 38, 722–732 (2010). This study provides the first evidence that ISG15 conjugation targets newly synthesized proteins. It demonstrates that overexpression of most proteins, along with the ISG15 conjugation cascade, can lead to their modification.
  CAS PubMed PubMed Central Google Scholar
• Zhao, C., Hsiang, T. Y., Kuo, R. L. & Krug, R. M. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl Acad. Sci. USA 107, 2253–2258 (2010).
  CAS PubMed Google Scholar
• Tang, Y. et al. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184, 5777–5790 (2010). Together with reference 55, this is one of the first studies to describe that a viral protein (IAV NS1) can be ISGylated.
  CAS PubMed Google Scholar
• Wang, X. et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74, 11566–11573 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bergmann, M. et al. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74, 6203–6206 (2000).
  CAS PubMed PubMed Central Google Scholar
• de la Luna, S., Fortes, P., Beloso, A. & Ortin, J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69, 2427–2433 (1995).
  PubMed PubMed Central Google Scholar
• Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3’end formation of cellular pre-mRNAs. Mol. Cell 1, 991–1000 (1998).
  CAS PubMed Google Scholar
• Fortes, P., Beloso, A. & Ortin, J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13, 704–712 (1994).
  CAS PubMed PubMed Central Google Scholar
• Zhao, C. et al. Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins. Nat. Commun. 7, 12754 (2016). This study finds that NS1/B binds to and sequesters ISGylated viral proteins, particularly ISGylated viral NPs, which prevents the incorporation of ISGylated NPs into NP oligomers, which was previously shown to inhibit viral RNA synthesis and viral replication.
  CAS PubMed PubMed Central Google Scholar
• Mathers, C., Schafer, X., Martinez-Sobrido, L. & Munger, J. The human cytomegalovirus UL26 protein antagonizes NF-kappaB activation. J. Virol. 88, 14289–14300 (2014).
  PubMed PubMed Central Google Scholar
• Kim, Y. J. et al. Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators. PLoS Pathog. 12, e1005850 (2016). This paper identifies HCMV viral proteins that antagonize the ISG15 pathway to facilitate viral infection.
  PubMed PubMed Central Google Scholar
• Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl Acad. Sci. USA 103, 1440–1445 (2006).
  CAS PubMed Google Scholar
• Sanyal, S. et al. Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. Cell Host Microbe 14, 510–521 (2013). This mechanistic study finds that ISGylation of host protein in the secretory pathway impedes influenza virus release.
  CAS PubMed PubMed Central Google Scholar
• Villarroya-Beltri, C. et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat. Commun. 7, 13588 (2016).
  CAS PubMed PubMed Central Google Scholar
• Yasuda, J., Nakao, M., Kawaoka, Y. & Shida, H. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 77, 9987–9992 (2003).
  CAS PubMed PubMed Central Google Scholar
• Malakhova, O. A. & Zhang, D. E. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283, 8783–8787 (2008).
  CAS PubMed PubMed Central Google Scholar
• Han, Z. et al. ITCH E3 ubiquitin ligase interacts with Ebola virus VP40 to regulate budding. J. Virol. 90, 9163–9171 (2016).
  CAS PubMed PubMed Central Google Scholar
• Pincetic, A. & Leis, J. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009, 6239691–6239699 (2009).
  PubMed Google Scholar
• Pincetic, A., Kuang, Z., Seo, E. J. & Leis, J. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725–4736 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kuang, Z., Seo, E. J. & Leis, J. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J. Virol. 85, 7153–7161 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dai, L. et al. Transcriptomic analysis of KSHV-infected primary oral fibroblasts: the role of interferon-induced genes in the latency of oncogenic virus. Oncotarget 7, 47052–47060 (2016).
  PubMed PubMed Central Google Scholar
• Jacobs, S. R. et al. Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor 1 interacts with a member of the interferon-stimulated gene 15 pathway. J. Virol. 89, 11572–11583 (2015). The study demonstrates that ISG15 regulates reactivation of latent virus.
  CAS PubMed PubMed Central Google Scholar
• Werneke, S. W. A. Role for Interferon Stimulated Gene-15 (ISG15) During Chikungunya Virus Infection Thesis, Washington Univ. (2013).
• Eduardo-Correia, B., Martinez-Romero, C., Garcia-Sastre, A. & Guerra, S. ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection. J. Virol. 88, 2312–2318 (2014).
  PubMed PubMed Central Google Scholar
• Soares, M. P., Teixeira, L. & Moita, L. F. Disease tolerance and immunity in host protection against infection. Nat. Rev. Immunol. 17, 83–96 (2017).
  CAS PubMed Google Scholar
• Shi, H. X. et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30, 2424–2436 (2010).
  CAS PubMed PubMed Central Google Scholar
• Katzenell, S. & Leib, D. A. Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons. J. Virol. 90, 4706–4719 (2016).
  CAS PubMed PubMed Central Google Scholar
• Falvey, C. M. et al. UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells. Oncotarget 8, 23479–23491 (2017).
  PubMed PubMed Central Google Scholar
• Malakhov, M. P. et al. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278, 16608–16613 (2003).
  CAS PubMed Google Scholar
• Okumura, F. et al. Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J. Biol. Chem. 288, 2839–2847 (2013).
  CAS PubMed Google Scholar
• Ganesan, M., Poluektova, L. Y., Tuma, D. J., Kharbanda, K. K. & Osna, N. A. Acetaldehyde disrupts interferon alpha signaling in hepatitis C virus-infected liver cells by up-regulating USP18. Alcohol Clin. Exp. Res. 40, 2329–2338 (2016).
  CAS PubMed PubMed Central Google Scholar
• Jones, D. M., Domingues, P., Targett-Adams, P. & McLauchlan, J. Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication. J. Gen. Virol. 91, 2238–2248 (2010).
  CAS PubMed Google Scholar
• Chen, L. et al. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J. Gen. Virol. 91, 382–388 (2010).
  CAS PubMed Google Scholar
• Broering, R. et al. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59, 1111–1119 (2010).
  CAS PubMed Google Scholar
• Chua, P. K. et al. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15. J. Gen. Virol. 90, 2929–2939 (2009).
  CAS PubMed Google Scholar
• Sung, P. S. et al. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. Proc. Natl Acad. Sci. USA 112, 10443–10448 (2015). This study shows that ISG15 sustains USP18-mediated interferon signalling, which impedes the effectiveness of an HCV therapy.
  CAS PubMed Google Scholar
• Sridharan, H., Zhao, C. & Krug, R. M. Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J. Biol. Chem. 285, 7852–7856 (2010).
  CAS PubMed PubMed Central Google Scholar
• Versteeg, G. A. et al. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J. Virol. 84, 5423–5430 (2010).
  CAS PubMed PubMed Central Google Scholar
• Guerra, S., Caceres, A., Knobeloch, K. P., Horak, I. & Esteban, M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4, e1000096 (2008). The study shows that vaccinia virus E3L protein functions as an immune-evasion protein by inhibiting ISG15 conjugate formation and is critical to viral pathogenesis.
  PubMed PubMed Central Google Scholar
• Frias-Staheli, N. et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2, 404–416 (2007). The study is the first to identify that viral OTU domain-containing proteins can function as both deubiquitinases and deISGylases.
  CAS PubMed PubMed Central Google Scholar
• Lindner, H. A. et al. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 79, 15199–15208 (2005).
  CAS PubMed PubMed Central Google Scholar
• Clementz, M. A. et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 84, 4619–4629 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mielech, A. M., Kilianski, A., Baez-Santos, Y. M., Mesecar, A. D. & Baker, S. C. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 450–451, 64–70 (2014). The study demonstrates that SARS and MERS PLpro also function as deubiquitinating and deISGylating enzymes.
  PubMed Google Scholar
• Chen, Z. et al. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J. Virol. 81, 6007–6018 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ma, X. Z. et al. Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis. J. Virol. 88, 6195–6204 (2014).
  CAS PubMed PubMed Central Google Scholar
• Deng, X. et al. A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses. J. Virol. 88, 11825–11833 (2014). This study shows that the deISGylase activity of a SARS PLpro has a critical role during infection by targeting the ISG15 pathway.
  PubMed PubMed Central Google Scholar
• Deaton, M. K. et al. Biochemical and structural insights into the preference of nairoviral DeISGylases for interferon-stimulated gene product 15 originating from certain species. J. Virol. 90, 8314–8327 (2016).
  CAS PubMed PubMed Central Google Scholar
• Bekes, M. et al. Recognition of Lys48-linked di-ubiquitin and deubiquitinating activities of the SARS coronavirus papain-like protease. Mol. Cell 62, 572–585 (2016).
  CAS PubMed PubMed Central Google Scholar
• Altun, M. et al. The human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages. PLoS ONE 10, e0115344 (2015).
  PubMed PubMed Central Google Scholar
• Bekes, M. et al. SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme. Biochem. J. 468, 215–226 (2015).
  CAS PubMed PubMed Central Google Scholar
• Deaton, M. K., Spear, A., Faaberg, K. S. & Pegan, S. D. The vOTU domain of highly-pathogenic porcine reproductive and respiratory syndrome virus displays a differential substrate preference. Virology 454–455, 247–253 (2014).
  PubMed Google Scholar
• Baez-Santos, Y. M., Mielech, A. M., Deng, X., Baker, S. & Mesecar, A. D. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. J. Virol. 88, 12511–12527 (2014).
  PubMed PubMed Central Google Scholar
• Ratia, K., Kilianski, A., Baez-Santos, Y. M., Baker, S. C. & Mesecar, A. Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease. PLoS Pathog. 10, e1004113 (2014).
  PubMed PubMed Central Google Scholar
• Daczkowski, C. M. et al. Structural insights into the interaction of coronavirus papain-like proteases and interferon-stimulated gene product 15 from different species. J. Mol. Biol. 429, 1661–1683 (2017).
  CAS PubMed PubMed Central Google Scholar
• Bianco, C. & Mohr, I. Restriction of human cytomegalovirus replication by ISG15, a host effector regulated by cGAS-STING double-stranded-DNA sensing. J. Virol. 91, e02483–16 (2017).
  CAS PubMed PubMed Central Google Scholar
• Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325–340 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gane, E. J. et al. The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection. J. Hepatol. 63, 320–328 (2015).
  CAS PubMed Google Scholar
• Janssen, H. L. A. et al. Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally-suppressed patients with chronic hepatitis B. J. Hepatol. 68, 431–440 (2018).
  CAS PubMed Google Scholar
• Villarreal, D. O. et al. Ubiquitin-like molecule ISG15 acts as an immune adjuvant to enhance antigen-specific CD8 T cell tumor immunity. Mol. Ther. 23, 1653–1662 (2015).
  CAS PubMed PubMed Central Google Scholar
• Malakhova, O. A. et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17, 455–460 (2003).
  CAS PubMed PubMed Central Google Scholar
• Tokarz, S. et al. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase. J. Biol. Chem. 279, 46424–46430 (2004).
  CAS PubMed Google Scholar
• Meuwissen, M. E. et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J. Exp. Med. 213, 1163–1174 (2016).
  PubMed PubMed Central Google Scholar
• Dauphinee, S. M. et al. Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections. Genes Immun. 15, 282–292 (2014).
  CAS PubMed PubMed Central Google Scholar
• Manca, C. et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694–701 (2005).
  CAS PubMed Google Scholar
• Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522–531 (2007).
  CAS PubMed Google Scholar
• Stanley, S. A., Johndrow, J. E., Manzanillo, P. & Cox, J. S. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178, 3143–3152 (2007).
  CAS PubMed Google Scholar
• Antonelli, L. R. et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120, 1674–1682 (2010).
  CAS PubMed PubMed Central Google Scholar
• Desvignes, L., Wolf, A. J. & Ernst, J. D. Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 188, 6205–6215 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dorhoi, A. et al. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur. J. Immunol. 44, 2380–2393 (2014).
  CAS PubMed PubMed Central Google Scholar
• Kimmey, J. M. et al. The impact of ISGylation during Mycobacterium tuberculosis infection in mice. Microbes Infect. 19, 249–258 (2017).
  CAS PubMed PubMed Central Google Scholar
• Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl Acad. Sci. USA 98, 5752–5757 (2001).
  CAS PubMed Google Scholar
• Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010).
  CAS PubMed PubMed Central Google Scholar
• Dong, C., Gao, N., Ross, B. X. & Yu, F. X. ISG15 in host defense against Candida albicans infection in a mouse model of fungal keratitis. Invest. Ophthalmol. Vis. Sci. 58, 2948–2958 (2017).
  CAS PubMed PubMed Central Google Scholar
• Cheon, H. et al. IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J. 32, 2751–2763 (2013).
  CAS PubMed PubMed Central Google Scholar
• Cheon, H. & Stark, G. R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl Acad. Sci. USA 106, 9373–9378 (2009).
  CAS PubMed Google Scholar
• Kim, K. I. et al. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling. J. Immunol. 175, 847–854 (2005).
  CAS PubMed Google Scholar
• Dao, C. T., Luo, J. K. & Zhang, D. E. Retinoic acid-induced protein ISGylation is dependent on interferon signal transduction. Blood Cells Mol. Dis. 36, 406–413 (2006).
  CAS PubMed Google Scholar
• Memet, S., Besancon, F., Bourgeade, M. F. & Thang, M. N. Direct induction of interferon-gamma- and interferon-alpha/beta-inducible genes by double-stranded RNA. J. Interferon Res. 11, 131–141 (1991).
  CAS PubMed Google Scholar
• Daly, C. & Reich, N. C. Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon alpha/beta-stimulated genes. J. Biol. Chem. 270, 23739–23746 (1995).
  CAS PubMed Google Scholar
• Weaver, B. K., Kumar, K. P. & Reich, N. C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359–1368 (1998).
  CAS PubMed PubMed Central Google Scholar
• Park, J. H. et al. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat. Commun. 7, 12513 (2016).
  CAS PubMed PubMed Central Google Scholar
• Chiu, Y. H., Sun, Q. & Chen, Z. J. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 27, 1014–1023 (2007).
  CAS PubMed Google Scholar
• Kim, K. I. et al. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol. Cell. Biol. 26, 472–479 (2006).
  CAS PubMed PubMed Central Google Scholar
• Krug, R. M., Zhao, C. & Beaudenon, S. Properties of the ISG15 E1 enzyme UbE1L. Methods Enzymol. 398, 32–40 (2005).
  CAS PubMed Google Scholar
• Zhao, C. et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl Acad. Sci. USA 101, 7578–7582 (2004).
  CAS PubMed Google Scholar
• Kim, K. I., Giannakopoulos, N. V., Virgin, H. W. & Zhang, D. E. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol. Cell. Biol. 24, 9592–9600 (2004).
  CAS PubMed PubMed Central Google Scholar
• Zou, W. & Zhang, D. E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281, 3989–3994 (2006).
  CAS PubMed Google Scholar
• Okumura, F., Zou, W. & Zhang, D. E. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 21, 255–260 (2007).
  CAS PubMed PubMed Central Google Scholar
• Dastur, A., Beaudenon, S., Kelley, M., Krug, R. M. & Huibregtse, J. M. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281, 4334–4338 (2006).
  CAS PubMed Google Scholar
• Wong, J. J., Pung, Y. F., Sze, N. S. & Chin, K. C. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc. Natl Acad. Sci. USA 103, 10735–10740 (2006).
  CAS PubMed Google Scholar
• Ketscher, L., Basters, A., Prinz, M. & Knobeloch, K. P. mHERC6 is the essential ISG15 E3 ligase in the murine system. Biochem. Biophys. Res. Commun. 417, 135–140 (2012).
  CAS PubMed Google Scholar
• Oudshoorn, D. et al. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS ONE 7, e29870 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hare, N. J. et al. Microparticles released from _Mycobacterium tuberculosis_-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics 15, 3020–3029 (2015).
  CAS PubMed Google Scholar
• Recht, M., Borden, E. C. & Knight, E. Jr. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147, 2617–2623 (1991).
  CAS PubMed Google Scholar
• Zaheer, R. S. et al. Human rhinovirus-induced ISG15 selectively modulates epithelial antiviral immunity. Mucosal Immunol. 7, 1127–1138 (2014).
  CAS PubMed PubMed Central Google Scholar
• Arimoto, K. I. et al. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling. Nat. Struct. Mol. Biol. 24, 279–289 (2017).
  CAS PubMed PubMed Central Google Scholar
• Rodriguez, M. R., Monte, K., Thackray, L. B. & Lenschow, D. J. ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle. J. Virol. 88, 9277–9286 (2014).
  PubMed PubMed Central Google Scholar
• Dai, J., Pan, W. & Wang, P. ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol. J. 8, 468 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kim, M. J. & Yoo, J. Y. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J. Immunol. 185, 4311–4318 (2010).
  CAS PubMed Google Scholar
• Tian, J. et al. Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes. Front. Microbiol. 6, 886 (2015).
  PubMed PubMed Central Google Scholar
• Gonzalez-Sanz, R. et al. ISG15 is upregulated in respiratory syncytial virus infection and reduces virus growth through protein ISGylation. J. Virol. 90, 3428–3438 (2016).
  CAS PubMed PubMed Central Google Scholar
• Singh, P. K. et al. Zika virus infects cells lining the blood-retinal barrier and causes chorioretinal atrophy in mouse eyes. JCI Insight 2, e92340 (2017).
  PubMed PubMed Central Google Scholar
• Hishiki, T. et al. Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication. Biochem. Biophys. Res. Commun. 448, 95–100 (2014).
  CAS PubMed Google Scholar
• Li, Y. et al. Interferon-stimulated gene 15 conjugation stimulates hepatitis B virus production independent of type I interferon signaling pathway in vitro. Mediators Inflamm. 2016, 7417648 (2016).
  PubMed PubMed Central Google Scholar
• Chavoshi, S. et al. Identification of Kaposi sarcoma herpesvirus (KSHV) vIRF1 protein as a novel interaction partner of human deubiquitinase USP7. J. Biol. Chem. 291, 6281–6291 (2016).
  CAS PubMed PubMed Central Google Scholar
• Bianco, C. & Mohr, I. Restriction of HCMV replication by ISG15, a host effector regulated by cGAS-STING dsDNA sensing. J. Virol. 91, e02483–16 (2017).
  CAS PubMed PubMed Central Google Scholar
• Foy, E. et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl Acad. Sci. USA 102, 2986–2991 (2005).
  CAS PubMed Google Scholar
• Sumpter, R. Jr. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase. RIG-I. J. Virol. 79, 2689–2699 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kim, M. J., Hwang, S. Y., Imaizumi, T. & Yoo, J. Y. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82, 1474–1483 (2008).
  CAS PubMed Google Scholar
• Huang, Y. F., Wee, S., Gunaratne, J., Lane, D. P. & Bulavin, D. V. Isg15 controls p53 stability and functions. Cell Cycle 13, 2200–2210 (2014).
  PubMed Google Scholar
• Park, J. M. et al. Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis. Mol. Cell 54, 626–638 (2014).
  CAS PubMed Google Scholar
• Lee, J. H. et al. Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9/CD82 and suppresses the Wnt/beta-catenin signal via ISGylation of beta-catenin. Gut 59, 907–917 (2010).
  CAS PubMed Google Scholar
• Yeh, Y. H., Yang, Y. C., Hsieh, M. Y., Yeh, Y. C. & Li, T. K. A negative feedback of the HIF-1alpha pathway via interferon-stimulated gene 15 and ISGylation. Clin. Cancer Res. 19, 5927–5939 (2013).
  CAS PubMed Google Scholar
• Im, E., Yoo, L., Hyun, M., Shin, W. H. & Chung, K. C. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin. Open Biol. 6, 160193 (2016).
  PubMed PubMed Central Google Scholar
• Cerikan, B. et al. Cell-intrinsic adaptation arising from chronic ablation of a key Rho GTPase regulator. Dev. Cell 39, 28–43 (2016).
  CAS PubMed Google Scholar
• Takeuchi, T. & Yokosawa, H. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem. Biophys. Res. Commun. 336, 9–13 (2005).
  CAS PubMed Google Scholar
• Takeuchi, T., Iwahara, S., Saeki, Y., Sasajima, H. & Yokosawa, H. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J. Biochem. 138, 711–719 (2005).
  CAS PubMed Google Scholar
• Takeuchi, T., Kobayashi, T., Tamura, S. & Yokosawa, H. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett. 580, 4521–4526 (2006).
  CAS PubMed Google Scholar
• Zou, W., Wang, J. & Zhang, D. E. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation. Biochem. Biophys. Res. Commun. 354, 321–327 (2007).
  CAS PubMed PubMed Central Google Scholar
• Feng, Q. et al. UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol. Cancer Ther. 7, 3780–3788 (2008).
  CAS PubMed PubMed Central Google Scholar
• Shah, S. J. et al. UBE1L represses PML/RARα by targeting the PML domain for ISG15ylation. Mol. Cancer Ther. 7, 905–914 (2008).
  CAS PubMed PubMed Central Google Scholar
• Jeon, Y. J. et al. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J. Clin. Invest. 122, 2622–2636 (2012).
  CAS PubMed PubMed Central Google Scholar